Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × Bleomycin × Clear all

Phase

Status

Unknown 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Germ Cell and Embryonal 2 Hodgkin Disease 2 Vulvar Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Seminoma 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Gynecological Cancers 1 Endodermal Sinus Tumor 1 Desmoid Tumors 1 Carcinoma, Embryonal 1

Interventions

Bevacizumab 36 Paclitaxel 27 Carboplatin 23 pembrolizumab 21 Specimen Handling 15 olaparib 13 Cisplatin 11 niraparib 10 Magnetic Resonance Spectroscopy 10 Cyclophosphamide 10 Blood Specimen Collection 10 fludarabine 8 Fulvestrant 8 Drug Therapy 8 Biopsy 8 Taxes 6 liposomal doxorubicin 5 Topotecan 5 Gemcitabine 5 Fluorouracil 5 Doxorubicin 5 mirvetuximab soravtansine 4 cemiplimab 4 aldesleukin 4 abemaciclib 4 Surveys and Questionnaires 4 Oxaliplatin 4 Interleukin-2 4 Immunoglobulin G 4 Hyperthermic Intraperitoneal Chemotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡